Arkamine (Isosorbide Dinitrate) Dosing for Angina Pectoris
Recommended Dosage
For angina pectoris, start isosorbide dinitrate at 5-20 mg two to three times daily, then titrate to a maintenance dose of 10-40 mg two to three times daily, ensuring a daily dose-free interval of at least 14 hours to prevent tolerance. 1
Initial Dosing Strategy
- Starting dose: Begin with 5-20 mg administered 2-3 times daily 1
- Timing: Administer doses with at least a 14-hour drug-free interval between the last dose of the day and first dose the next morning 1
- The dose-free interval is critical because continuous 24-hour plasma levels cause refractory tolerance, rendering the medication ineffective 1
Maintenance Dosing
- Standard maintenance: 10-40 mg two to three times daily 1
- Higher doses: Some patients may require doses above 40 mg per administration 1
- The FDA label emphasizes administering the minimum dose that produces the desired clinical effect 1
Duration of Action and Tolerance Considerations
- Effective coverage: No dosing regimen should be expected to provide more than approximately 12 hours of continuous anti-anginal efficacy per day 2
- Tolerance development: The effects of the second and later doses are typically smaller and shorter-lasting than the first dose 1
- Research demonstrates that with three-times-daily dosing, anti-anginal effects may return to baseline within 3-5 hours after each dose, despite continued plasma drug levels 3
- During sustained therapy, partial tolerance develops rapidly—exercise tolerance improvements that last 8 hours during acute therapy persist for only 2 hours during chronic treatment 4
Practical Dosing Schedules
Recommended timing to maximize efficacy while preventing tolerance:
- 8 AM dose: Provides coverage for morning and midday activities
- 1 PM dose: Covers afternoon period
- 6 PM dose: Provides early evening protection
- Overnight drug-free interval: From 6 PM until 8 AM (14 hours) 3
This schedule aligns with the ACC/AHA guideline recommendations for unstable angina, which specify isosorbide dinitrate 5-80 mg administered 2-3 times daily 2
Dose-Response Relationship
- Minimal effective dose: Studies show that 15-30 mg produces similar exercise tolerance improvement as 60-120 mg doses 4
- During sustained therapy, 15 mg four times daily produces the same magnitude of benefit as higher doses (30,60, or 120 mg four times daily) 4
- Clinical implication: Most patients achieve near-maximal improvement with 15-30 mg doses, making higher doses unnecessary for most patients 4
Special Considerations and Pitfalls
Critical contraindications:
- Avoid in patients taking phosphodiesterase-5 inhibitors (sildenafil within 24 hours, tadalafil within 48 hours) due to risk of profound hypotension and death 2, 5
- Do not use if systolic blood pressure <90 mmHg or >30 mmHg below baseline 2
- Avoid with marked bradycardia or tachycardia 2
Common adverse effects:
- Headache (most frequent)
- Dizziness
- Hypotension 2
Tolerance mitigation:
- The 14-hour drug-free interval is non-negotiable for maintaining long-term efficacy 1
- Increasing doses to overcome tolerance is generally ineffective and not recommended 4
- If breakthrough angina occurs during the drug-free interval, consider adding a beta-blocker or calcium channel blocker rather than extending nitrate coverage 2
Alternative Formulations
For patients requiring different dosing schedules:
- Slow-release oral: 40 mg once or twice daily with appropriate drug-free intervals 2
- Sublingual: 5-10 mg as needed for acute episodes 2
Monitoring Parameters
- Blood pressure (particularly systolic) before each dose escalation
- Frequency of anginal episodes and nitroglycerin use
- Exercise tolerance
- Headache severity (may improve with continued use) 2